Celgene Corporation

Anthrogenesis Corporation

Other

Celularity Inc.

David I. Stirling

Andrew L. Zeitlin

Clarity Acquisition II LLC

Jerome B. Zeldis

Maghsoud M. Dariani

Herbert Faleck

Vikram Khetani

Robert J Hariri

James W Edinger

Qian Ye

Jia-Lun Wang

Jerome B Zeldis

Andrew L Zeitlin

Maghsoud M Dariani

Kristen S Labazzo

Sascha Dawn Abramson

Marian Pereira

Donald C Manning

David Sterling

Jia-Iun Wang

Marian Periera

David I Stirling

Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.

Treatment of inflammatory diseases using placental stem cells

Treatment of psoriasis using placental stem cells

Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline

In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising D-threo methylphenidate that is substantially free of L-threo methylphenidate and of erythro forms of methylphenidate.

Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate

Growing community of inventors

West Orange, NJ, United States of America

Herbert Faleck